Patrick William Tuer Sells 682 Shares of Encompass Health (NYSE:EHC) Stock

Encompass Health Corporation (NYSE:EHC) EVP Patrick William Tuer sold 682 shares of Encompass Health stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $104.56, for a total value of $71,309.92. Following the completion of the transaction, the executive vice president owned 24,755 shares of the company’s stock, valued at approximately $2,588,382.80. The trade was a 2.68% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Encompass Health Trading Down 0.6%

Shares of NYSE EHC opened at $107.40 on Thursday. The company has a market cap of $10.65 billion, a price-to-earnings ratio of 17.93, a price-to-earnings-growth ratio of 2.35 and a beta of 0.72. Encompass Health Corporation has a 12-month low of $92.77 and a 12-month high of $127.99. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.76. The stock’s 50 day simple moving average is $103.01 and its 200 day simple moving average is $106.54.

Encompass Health (NYSE:EHC) last announced its quarterly earnings results on Thursday, April 30th. The company reported $1.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.51 by $0.09. The business had revenue of $1.59 billion for the quarter, compared to the consensus estimate of $1.57 billion. Encompass Health had a return on equity of 18.28% and a net margin of 10.04%.The business’s revenue was up 9.0% on a year-over-year basis. During the same quarter last year, the business posted $1.37 EPS. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. Equities research analysts expect that Encompass Health Corporation will post 5.97 EPS for the current year.

Encompass Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be issued a $0.19 dividend. The ex-dividend date of this dividend is Wednesday, July 1st. This represents a $0.76 annualized dividend and a dividend yield of 0.7%. Encompass Health’s dividend payout ratio (DPR) is 12.69%.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on EHC. Barclays cut their price target on Encompass Health from $153.00 to $140.00 and set an “overweight” rating on the stock in a report on Tuesday, May 5th. Wall Street Zen raised Encompass Health from a “hold” rating to a “buy” rating in a report on Saturday, May 2nd. Two investment analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat, Encompass Health currently has an average rating of “Buy” and an average target price of $144.17.

Hedge Funds Weigh In On Encompass Health

A number of hedge funds have recently modified their holdings of EHC. Royal Bank of Canada grew its holdings in shares of Encompass Health by 21.5% in the 1st quarter. Royal Bank of Canada now owns 88,470 shares of the company’s stock worth $8,960,000 after acquiring an additional 15,677 shares during the last quarter. Millennium Management LLC grew its holdings in shares of Encompass Health by 38.4% in the 1st quarter. Millennium Management LLC now owns 92,197 shares of the company’s stock worth $9,338,000 after acquiring an additional 25,574 shares during the last quarter. Caxton Associates LLP acquired a new position in shares of Encompass Health in the 1st quarter worth $259,000. Walleye Capital LLC grew its holdings in shares of Encompass Health by 667.6% in the 2nd quarter. Walleye Capital LLC now owns 6,522 shares of the company’s stock worth $800,000 after acquiring an additional 7,671 shares during the last quarter. Finally, Gamco Investors INC. ET AL acquired a new position in shares of Encompass Health in the 2nd quarter worth $588,000. 97.25% of the stock is currently owned by institutional investors and hedge funds.

About Encompass Health

Encompass Health Corporation is a leading provider of post?acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end?of?life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.